Cambridge Investment Research Advisors’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-582,855
| Closed | -$29K | – | 2453 |
|
2019
Q2 | $29K | Buy |
+582,855
| New | +$29K | ﹤0.01% | 2172 |
|
2018
Q3 | – | Sell |
-1,030,310
| Closed | -$876K | – | 2352 |
|
2018
Q2 | $876K | Buy |
1,030,310
+49,967
| +5% | +$42.5K | 0.01% | 1054 |
|
2018
Q1 | $1.48M | Sell |
980,343
-39,225
| -4% | -$59.2K | 0.02% | 742 |
|
2017
Q4 | $2.14M | Buy |
1,019,568
+187,834
| +23% | +$394K | 0.03% | 564 |
|
2017
Q3 | $1.62M | Buy |
+831,734
| New | +$1.62M | 0.02% | 608 |
|